scispace - formally typeset
W

Wenyi Wang

Researcher at University of Texas MD Anderson Cancer Center

Publications -  123
Citations -  22012

Wenyi Wang is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Biology. The author has an hindex of 28, co-authored 92 publications receiving 16322 citations. Previous affiliations of Wenyi Wang include Johns Hopkins University & University of Texas Health Science Center at Houston.

Papers
More filters
Journal ArticleDOI

Pan-cancer analysis of whole genomes

Peter J. Campbell, +1332 more
- 06 Feb 2020 - 
TL;DR: The flagship paper of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium describes the generation of the integrative analyses of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types, the structures for international data sharing and standardized analyses, and the main scientific findings from across the consortium studies.
Journal ArticleDOI

The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma

Caleb F. Davis, +225 more
- 08 Sep 2014 - 
TL;DR: Genomic rearrangements lead to recurrent structural breakpoints within TERT promoter region, which correlates with highly elevated TERT expression and manifestation of kataegis, representing a mechanism of TERT upregulation in cancer distinct from previously observed amplifications and point mutations.
Journal ArticleDOI

The evolutionary history of 2,658 cancers

Moritz Gerstung, +64 more
- 06 Feb 2020 - 
TL;DR: Whole-genome sequencing data for 2,778 cancer samples from 2,658 unique donors is used to reconstruct the evolutionary history of cancer, revealing that driver mutations can precede diagnosis by several years to decades.
Posted ContentDOI

The evolutionary history of 2,658 cancers

TL;DR: Whole-genome sequencing of 2,778 tumour samples from 2,658 donors is used to reconstruct the life history, evolution of mutational processes, and driver mutation sequences of 39 cancer types, suggesting a window of opportunity for early cancer detection.